How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals (RXRX) saw a sharp uptick in trading as investors looked ahead to the CEO's upcoming presentation at a major AI conference. The focus is on how the company’s AI strategy and ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Shopping will now save the planet. Florida Governor Ron DeSantis announced this week that the state is taking an uncharacteristically classy approach to tackling one of its most notorious ecological ...

Discover Denario, the new open-source AI that automates the entire scientific process, from generating hypotheses to ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Follow ZDNET: Add us as a preferred source on Google. When Windows decides that it isn't interested in completing an upgrade, it can be maddeningly unhelpful ...

Editor's Note: The YouTube outage has now been resolved. Read an update on Thursday, Oct. 16. YouTube experienced technical difficulties on Wednesday, Oct. 15, with hundreds of thousands of users ...